ABBV
50
-9
PRU
77
-2
SIG
52
5
BK
68
-6
RL
75
-4
L
65
-4
EBAY
48
-4
ECL
52
-2
CNX
49
-3
ISRG
66
-2
GS
72
-3
CSCO
58
-2
PM
60
-2
MU
56
-6
URBN
70
-4
MAC
65
-3
ILMN
68
-2
CCL
64
-4
EIX
54
-2
JBHT
63
-2
ABBV
50
-9
PRU
77
-2
SIG
52
5
BK
68
-6
RL
75
-4
L
65
-4
EBAY
48
-4
ECL
52
-2
CNX
49
-3
ISRG
66
-2
GS
72
-3
CSCO
58
-2
PM
60
-2
MU
56
-6
URBN
70
-4
MAC
65
-3
ILMN
68
-2
CCL
64
-4
EIX
54
-2
JBHT
63
-2
Financhill
Back

Columbia Seligman Premium Technology Growth Fund Vs. Nektar Therapeutics Industry Stock Comparison

Buy
55

STK
Columbia Seligman Premium Technology Growth Fund

Last Price:
$34.71
Seasonality Move:
0.87%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Buy
55
Columbia Seligman Premium Technology Growth Fund (STK) is a Buy

Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?

  • The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $35.45. The Score for STK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • STK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STK Stock Price Chart

What is Columbia Seligman Premium Technology Growth Fund's stock price today?

  • The Columbia Seligman Premium Technology Growth Fund share price today is $35.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STK is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

STK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 40.44 Sell
Chaikin Money Flow: 16137 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

STK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.84 Sell
20-day SMA: 36.09 Sell
50-day SMA: 36.85 Sell
200-day SMA: 31.84 Buy
8-day EMA: 36.38 Sell
20-day EMA: 36.58 Sell
50-day EMA: 36.27 Sell
200-day EMA: 33.55 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Columbia Seligman Premium Technology Growth Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):